GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Tong Ren Tang Chinese Medicine Co Ltd (HKSE:03613) » Definitions » Cash Flow from Investing

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Cash Flow from Investing : HK$-1,079 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Beijing Tong Ren Tang Chinese Medicine Co Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Dec. 2023, Beijing Tong Ren Tang Chinese Medicine Co spent HK$15 Mil on purchasing property, plant, equipment. It gained HK$0 Mil from selling property, plant, and equipment. It spent HK$0 Mil on purchasing business. It gained HK$0 Mil from selling business. It spent HK$0 Mil on purchasing investments. It gained HK$0 Mil from selling investments. It paid HK$0Mil for net Intangibles purchase and sale. And it paid HK$713 Mil for other investing activities. In all, Beijing Tong Ren Tang Chinese Medicine Co spent HK$727 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Dec. 2023.


Beijing Tong Ren Tang Chinese Medicine Co Cash Flow from Investing Historical Data

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tong Ren Tang Chinese Medicine Co Cash Flow from Investing Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 835.54 506.73 -265.73 335.41 -1,078.52

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -643.74 -1,033.59 1,369.00 -351.04 -727.48

Beijing Tong Ren Tang Chinese Medicine Co Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Beijing Tong Ren Tang Chinese Medicine Co's Cash Flow from Investing for the fiscal year that ended in Dec. 2023 is calculated as:

Beijing Tong Ren Tang Chinese Medicine Co's Cash Flow from Investing for the quarter that ended in Dec. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1,079 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Tong Ren Tang Chinese Medicine Co  (HKSE:03613) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Beijing Tong Ren Tang Chinese Medicine Co's purchase of property, plant, equipment for the six months ended in Dec. 2023 was HK$-15 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co spent HK$15 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Beijing Tong Ren Tang Chinese Medicine Co's sale of property, plant, equipment for the six months ended in Dec. 2023 was HK$0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co gained HK$0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Beijing Tong Ren Tang Chinese Medicine Co's purchase of business for the six months ended in Dec. 2023 was HK$0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co spent HK$0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Beijing Tong Ren Tang Chinese Medicine Co's sale of business for the six months ended in Dec. 2023 was HK$0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co gained HK$0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Beijing Tong Ren Tang Chinese Medicine Co's purchase of investment for the six months ended in Dec. 2023 was HK$0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Beijing Tong Ren Tang Chinese Medicine Co's sale of investment for the six months ended in Dec. 2023 was HK$0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co gained HK$0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Beijing Tong Ren Tang Chinese Medicine Co's net Intangibles purchase and sale for the six months ended in Dec. 2023 was HK$0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co paid HK$0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Beijing Tong Ren Tang Chinese Medicine Co's cash from discontinued investing activities for the six months ended in Dec. 2023 was 0 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co paid HK$0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Beijing Tong Ren Tang Chinese Medicine Co's cash from other investing activities for the six months ended in Dec. 2023 was HK$-713 Mil. It means Beijing Tong Ren Tang Chinese Medicine Co paid HK$713 Mil for other investing activities.


Beijing Tong Ren Tang Chinese Medicine Co Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Beijing Tong Ren Tang Chinese Medicine Co's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Business Description

Traded in Other Exchanges
Address
Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products, Mainland China (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Mainland China and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd, and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Headlines

No Headlines